RNA as of Oct 31 · 06:33 ET
RNANasdaqPharmaceutical Preparations

Atrium Therapeutics, Inc. · Brief

Next report

No upcoming report date.

Expected move

No implied move.

Implied vs realized

2 reportsHistory
—≥ implied
Q1 FY26±3.0%▼−0.30%×0.10
Q2 FY26—▲+4.14%—
quarterimplied−5%0+5%realized×
Q2 FY26—▲+4.14%—
Q1 FY26±3.0%▼−0.30%×0.10
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Bull1

5tracked funds holding RNAN-PORT · Aug 31 '26

Bear1

7 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

RNA report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 88-KMaterial agreement: 8-K Item 1.01.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.